Eledon Pharmaceuticals

(NASDAQ) ELDN

Current Price$3.85

Market Cap$288.24M

Since IPO (2017)-97%

5 Year-57%

1 Year+32%

1 Month+23%

Eledon Pharmaceuticals Financials at a Glance

Market Cap

$288.24M

Revenue (TTM)

$0.00

Net Income (TTM)

$45.62M

EPS (TTM)

$-0.59

P/E Ratio

-6.39

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$3.85

Volume

61,950

Open

$3.80

Price

$3.85

Volume

61,950

Open

$3.80

Previous Close

$3.85

Daily Range

$3.71 - $3.92

52-Week Range

$1.35 - $4.60

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$3.85

Volume

61,950

Open

$3.80

Previous Close

$3.85

Daily Range

$3.71 - $3.92

52-Week Range

$1.35 - $4.60

ELDN News

Eledon Posts Narrower Loss in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eledon Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David-Alexandre C. Gros, MD, MBA

Website

eledon.com

Headquarters

Irvine, CA 92612, US

ELDN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-36%

Return on Capital

-38%

Return on Assets

-19%

Earnings Yield

-15.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$288.24M

Shares Outstanding

75.85M

Volume

61.95K

Avg. Volume

1.40M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$83.25M

EBITDA

$83.25M

Operating Cash Flow

$62.34M

Capital Expenditure

$0.00

Free Cash Flow

$62.34M

Cash & ST Invst.

$133.34M

Total Debt

$641.00K

Eledon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$288.24M

N/A

Market Cap/Employee

$9.30M

N/A

Employees

N/A

Net Income

$10.45M

+76.6%

EBITDA

$21.48M

+51.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$132.69M

-4.7%

Accounts Receivable

$514.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$283.00K

-55.8%

Short Term Debt

$358.00K

+14.0%

Return on Assets

-19.20%

N/A

Return on Invested Capital

-37.97%

N/A

Free Cash Flow

$14.09M

+25.8%

Operating Cash Flow

$14.09M

+25.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$3.03-4.57%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.85-57.27%

ACHVAchieve Life Sciences, Inc.

ACHVAchieve Life Sciences, Inc.$4.79-0.21%

ABEOAbeona Therapeutics Inc.

ABEOAbeona Therapeutics Inc.$5.77-3.99%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.96-5.04%

PBYIPuma Biotechnology, Inc.

PBYIPuma Biotechnology, Inc.$7.26-2.55%

VNDAVanda Pharmaceuticals Inc.

VNDAVanda Pharmaceuticals Inc.$6.39-14.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

INTCIntel

INTCIntel$109.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

IRENIren

IRENIren$56.85-0.07%

Questions About ELDN

What is the current price of Eledon Pharmaceuticals?

Eledon Pharmaceuticals is trading at $3.86 per share.

What is the 52-week range for Eledon Pharmaceuticals?

Over the past 52 weeks, Eledon Pharmaceuticals has traded between $1.35 and $4.60.

How much debt does Eledon Pharmaceuticals have?

As of the most recent reporting period, Eledon Pharmaceuticals reported total debt of $641,000.

How much cash does Eledon Pharmaceuticals have on hand?

Eledon Pharmaceuticals reported $22.81M in cash and cash equivalents in its most recent financial results.

What is Eledon Pharmaceuticals’s dividend yield?

Eledon Pharmaceuticals does not currently have a dividend yield.

Eledon Pharmaceuticals

Eledon Pharmaceuticals Financials at a Glance

ELDN News

Eledon Posts Narrower Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Eledon Pharmaceuticals

ELDN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Eledon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ELDN

What is the current price of Eledon Pharmaceuticals?

What is the 52-week range for Eledon Pharmaceuticals?

How much debt does Eledon Pharmaceuticals have?

How much cash does Eledon Pharmaceuticals have on hand?

What is Eledon Pharmaceuticals’s dividend yield?

Premium Investing Services